Pith. sign in

REVIEW 3 major objections 2 minor 15 references

Reviewed by Pith at T0; open to challenge.

T0 means a machine referee read the full paper against a public rubric. The mark states how deep the mechanical check went, never who wrote it. the ladder, T0–T4 →

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

T0 review · grok-4.3

Two-stage fine-tuning of ResNet50 raises melanoma detection sensitivity above 87 percent on dermoscopic images.

2026-06-27 05:25 UTC pith:FJVKRSMO

load-bearing objection Two-stage fine-tuning on ResNet50 produces usable melanoma metrics but the class-stratified split leaves patient-level leakage unaddressed and the 4% gain lacks statistical support. the 3 major comments →

arxiv 2606.17504 v1 pith:FJVKRSMO submitted 2026-06-11 eess.IV cs.CV

Two-Stage Fine-Tuning of ResNet50 for High-Sensitivity Melanoma Detection on Dermoscopic Images

Aryan Bhagat This is my paper
classification eess.IV cs.CV
keywords melanoma detectionResNet50fine-tuningdermoscopic imagesclass imbalancetransfer learningskin cancer classificationdeep learning
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper establishes that a two-stage protocol for fine-tuning ResNet50 improves binary melanoma classification by first training only the head with the base frozen, then jointly updating all layers at a low learning rate after balancing the training classes via oversampling. A sympathetic reader would care because melanoma survival drops sharply after early stages, and this method offers a straightforward way to boost sensitivity without new architectures or external data. The ablation shows the staged approach outperforms single-stage fine-tuning by more than four percentage points in sensitivity on a held-out test set of 3,826 images. The resulting model reaches an AUC-ROC of 0.9559 while producing Grad-CAM maps that align with lesion locations. The work also supplies deployable code and a Streamlit interface.

Core claim

The central claim is that the two-stage fine-tuning protocol, consisting of an initial phase that trains only the classification head on oversampled balanced data with the ResNet50 backbone frozen followed by a second phase that unfreezes and jointly optimizes all layers at a learning rate of 1e-5, produces an unbiased high-sensitivity classifier for melanoma versus benign lesions on dermoscopic images, delivering 87.56 percent sensitivity, 89.13 percent specificity, and 0.9559 AUC-ROC on an independent test set while outperforming single-stage fine-tuning.

What carries the argument

The two-stage fine-tuning protocol that first trains the classification head alone with the pretrained base frozen and then fine-tunes the entire network at low learning rate after training-set-only oversampling.

Load-bearing premise

Random oversampling applied only to the training split combined with a stratified split and low learning rate fully prevents data leakage and catastrophic forgetting of ImageNet features.

What would settle it

A replication experiment on the same 3,826-image test set that finds single-stage fine-tuning without the staged protocol achieves equal or higher sensitivity while maintaining the same train-validation-test split.

Watch this falsifier — get emailed when new claim-graph text bears on it.

If this is right

  • The staged protocol reduces sensitivity loss from class imbalance in binary medical imaging tasks.
  • The low learning rate in the second stage preserves useful visual features learned from ImageNet.
  • Grad-CAM outputs align with actual lesion regions, supporting interpretability for clinical review.
  • The provided Streamlit application allows direct deployment of the trained model on new dermoscopic images.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same staged protocol could be tested on other imbalanced medical imaging problems such as chest X-ray abnormality detection.
  • Adding geometric augmentations during the second stage might further lift performance without changing the core schedule.
  • External validation on images from different dermoscopy devices would test whether the reported metrics generalize beyond the current dataset.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 2 minor

Summary. The manuscript proposes a two-stage fine-tuning protocol for ResNet50 on dermoscopic images for binary melanoma vs. benign classification. After class-stratified train/val/test splitting and random oversampling applied only to the training split, Stage 1 trains only the classification head with the backbone frozen; Stage 2 unfreezes all layers and fine-tunes at a fixed learning rate of 1e-5. On a held-out test set of 3,826 images the model reports AUC-ROC 0.9559, accuracy 88.34%, sensitivity 87.56%, specificity 89.13% and F1 88.29%. An ablation shows the two-stage schedule yields >4% higher sensitivity than single-stage fine-tuning. Grad-CAM visualizations and a Streamlit deployment with full training code are also provided.

Significance. If the test-set independence holds, the work supplies a concrete, reproducible demonstration that a low-LR second-stage fine-tuning step improves sensitivity on an imbalanced medical imaging task while preserving ImageNet features. The release of complete training code and a deployable application is a clear strength that facilitates direct replication and extension.

major comments (3)
  1. [Methods (Data Splitting)] Data splitting procedure (Methods): The manuscript states only that a 'stratified train/validation/test splitting' was performed and that oversampling was restricted to the training set. No mention is made of patient-level grouping or de-duplication. Because dermoscopic collections routinely contain multiple images per patient, an image-level split alone permits patient-specific artifacts or lesion appearances to leak across partitions, rendering both the absolute metrics (AUC 0.9559, sensitivity 87.56%) and the ablation comparison unreliable.
  2. [Results (Ablation)] Ablation study (Results): The claim that the two-stage protocol 'significantly outperforms' single-stage fine-tuning with 'sensitivity gains of over 4%' is presented without any statistical test (McNemar, bootstrap CI, or paired t-test across runs) or variance estimate. Consequently the reported improvement cannot be distinguished from sampling variability on the single 3,826-image test set.
  3. [Abstract and Methods] Dataset provenance (Abstract/Methods): No dataset name, acquisition protocol, ethical approval statement, or train/val/test size breakdown is supplied. Without this information it is impossible to assess selection bias, class distribution, or whether the 3,826-image test set overlaps with publicly available collections, directly affecting the generalizability of the headline performance figures.
minor comments (2)
  1. [Methods (Training)] The learning-rate value 1e-5 is stated without reference to a hyper-parameter search or sensitivity analysis; a brief justification or grid-search summary would strengthen the protocol description.
  2. [Results (Visualization)] Grad-CAM figures are referenced but lack quantitative localization metrics (e.g., pointing-game accuracy or IoU with lesion masks); adding such measures would make the visualization claim more rigorous.

Simulated Author's Rebuttal

3 responses · 0 unresolved

We thank the referee for the constructive comments on data handling, statistical rigor, and transparency. We address each major point below and will revise the manuscript to strengthen these aspects.

read point-by-point responses

  1. Referee: [Methods (Data Splitting)] Data splitting procedure (Methods): The manuscript states only that a 'stratified train/validation/test splitting' was performed and that oversampling was restricted to the training set. No mention is made of patient-level grouping or de-duplication. Because dermoscopic collections routinely contain multiple images per patient, an image-level split alone permits patient-specific artifacts or lesion appearances to leak across partitions, rendering both the absolute metrics (AUC 0.9559, sensitivity 87.56%) and the ablation comparison unreliable.

    Authors: We agree that patient-level de-duplication and splitting are best practice to minimize leakage in dermoscopic datasets. Our split was performed at the image level after stratification. We will revise the Methods section to explicitly describe the splitting procedure, note the absence of patient-level grouping, and add a limitations paragraph discussing the risk of intra-patient correlation. If the underlying collection permits reliable patient identifiers, we will explore re-splitting at the patient level for a future version; otherwise the current results remain valid under the image-level independence assumption stated in the paper. revision: partial

  2. Referee: [Results (Ablation)] Ablation study (Results): The claim that the two-stage protocol 'significantly outperforms' single-stage fine-tuning with 'sensitivity gains of over 4%' is presented without any statistical test (McNemar, bootstrap CI, or paired t-test across runs) or variance estimate. Consequently the reported improvement cannot be distinguished from sampling variability on the single 3,826-image test set.

    Authors: The referee is correct that no statistical test or variance estimate was provided for the ablation. We will recompute the sensitivity difference with bootstrap confidence intervals (1,000 resamples) and include McNemar’s test for paired predictions on the fixed test set. The revised Results section will report these statistics alongside the 4%+ sensitivity gain to substantiate the claim. revision: yes

  3. Referee: [Abstract and Methods] Dataset provenance (Abstract/Methods): No dataset name, acquisition protocol, ethical approval statement, or train/val/test size breakdown is supplied. Without this information it is impossible to assess selection bias, class distribution, or whether the 3,826-image test set overlaps with publicly available collections, directly affecting the generalizability of the headline performance figures.

    Authors: We will expand both the Abstract and Methods sections to name the dataset, describe the acquisition protocol and any preprocessing, state the ethical approval (or waiver) reference, and provide the exact train/validation/test image counts and class distributions. These details were inadvertently omitted from the initial submission and will be restored in the revision. revision: yes

Circularity Check

0 steps flagged

No circularity; empirical metrics from held-out test evaluation

full rationale

The paper reports standard supervised learning results: a ResNet50 model is trained on a training split (with oversampling) and evaluated directly on a held-out test set of 3826 images to obtain AUC, accuracy, sensitivity etc. The ablation compares two-stage vs single-stage training on identical splits. No equations, fitted parameters renamed as predictions, self-citations used as load-bearing uniqueness theorems, or ansatzes smuggled via prior work appear in the provided text. All performance numbers are external measurements against the test data, satisfying the self-contained benchmark criterion.

Axiom & Free-Parameter Ledger

1 free parameters · 2 axioms · 0 invented entities

The work rests on standard assumptions of transfer learning from ImageNet-pretrained weights, the validity of random oversampling for balance, and the representativeness of the (unspecified) dermoscopic dataset; no new entities or ad-hoc constants are introduced beyond the learning-rate choice of 1e-5.

free parameters (1)
  • learning_rate_stage2
    Set to 1e-5 to avoid catastrophic forgetting; value chosen by the authors rather than derived.
axioms (2)
  • domain assumption ResNet50 weights pretrained on ImageNet provide useful visual features for dermoscopic images
    Invoked by freezing the base in stage 1 and fine-tuning from those weights.
  • domain assumption Stratified split plus oversampling on train only yields unbiased test performance
    Central to the reported metrics and ablation.

pith-pipeline@v0.9.1-grok · 5754 in / 1436 out tokens · 19955 ms · 2026-06-27T05:25:15.087349+00:00 · methodology

0 comments
read the original abstract

Melanoma is the most dangerous form of skin cancer with five-year survival rates exceeding 99% when detected early but falling sharply once the disease spreads. This paper proposes and evaluates a two-stage fine-tuning approach for ResNet50 applied to binary melanoma classification on dermoscopic images. The core challenges addressed are class imbalance and suboptimal transfer learning from single-stage fine-tuning. After stratified train/validation/test splitting, random oversampling was applied exclusively to the training set to achieve a 1:1 class balance. Stage 1 trained only the classification head with the ResNet50 base frozen, while Stage 2 fine-tuned all layers jointly at a low learning rate of 1e-5 to prevent catastrophic forgetting of learned visual features. On an independent test set of 3,826 images, the model achieved an AUC-ROC of 0.9559, accuracy of 88.34%, sensitivity of 87.56%, specificity of 89.13%, and F1-score of 88.29%. An ablation study confirms the two-stage protocol significantly outperforms single-stage fine-tuning, with sensitivity gains of over 4%. Grad-CAM visualizations demonstrate correct lesion localization. A fully deployable Streamlit detection application is provided alongside all training code.

Figures

Figures reproduced from arXiv: 2606.17504 by Aryan Bhagat.

Figure 1
Figure 1. Figure 1: Dataset preparation and class balancing pipeline. The [PITH_FULL_IMAGE:figures/full_fig_p004_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Confusion matrix for melanoma detection on the independent test set (N=3,826). TP=1,675 | [PITH_FULL_IMAGE:figures/full_fig_p008_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: ROC curve for the two-stage fine-tuned ResNet50 on the independent test set (N=3,826). AUC￾ROC = 0.9559. Red dot marks the operating point at threshold 0.5 [PITH_FULL_IMAGE:figures/full_fig_p008_3.png] view at source ↗

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

15 extracted references · 2 canonical work pages · 1 internal anchor

  1. [1]

    Tschandl, P., Rosendahl, C., and Kittler, H. (2018). The HAM10000 dataset, a large collection of multi -source dermatoscopic images of common pigmented skin lesions. Scientific Data, 5, 180161

    2018

  2. [2]

    He, K., Zhang, X., Ren, S., and Sun, J. (2016). Deep residual learning for image recognition. In Proceedings of CVPR, pp. 770-778

    2016

  3. [3]

    A., Ko, J., Swetter, S

    Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., and Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118

    2017

  4. [4]

    Skin Lesion Analysis Toward Melanoma Detection 2018: A Challenge Hosted by the International Skin Imaging Collaboration (ISIC)

    Codella, N., Rotemberg, V., Tschandl, P., Celebi, M. E., Dusza, S., Gutman, D., and Kittler, H. (2019). Skin lesion analysis toward melanoma detection 2018. arXiv:1902.03368

    work page internal anchor Pith review Pith/arXiv arXiv 2019

  5. [5]

    Rotemberg, V., Kurtansky, N., Betz-Stablein, B., Caffery, L., Chousakos, E., Codella, N., and Tschandl, P. (2021). A patient-centric dataset of images and metadata for identifying melanomas. Scientific Data, 8(1), 34

    2021

  6. [6]

    Gessert, N., Nielsen, M., Shaikh, M., Werner, R., and Schlaefer, A. (2020). Skin lesion classification using ensembles of multi -resolution EfficientNets with meta data. MethodsX, 7, 100864

    2020

  7. [7]

    and Li, X

    Zhang, P. and Li, X. (2024). Hybrid deep learning framework for enhanced melanoma detection. arXiv:2408.00772

    work page arXiv 2024

  8. [8]

    Adegun, A. A. and Viriri, S. (2023). Early melanoma detection based on a hybrid YOLOv5 and ResNet technique. Diagnostics, 13(17), 2804

    2023

  9. [9]

    Yosinski, J., Clune, J., Bengio, Y., and Lipson, H. (2014). How transferable are features in deep neural networks? NeurIPS 27, 3320-3328

    2014

  10. [10]

    Kawahara, J., BenTaieb, A., and Hamarneh, G. (2016). Deep features to classify skin lesions. In IEEE ISBI, pp. 1397-1400

    2016

  11. [11]

    Chollet, F. (2017). Xception: Deep learning with depthwise separable convolutions. In Proceedings of CVPR, pp. 1251-1258

    2017

  12. [12]

    and Le, Q

    Tan, M. and Le, Q. V. (2019). EfficientNet: Rethinking model scaling for convolutional neural networks. In ICML, pp. 6105-6114

    2019

  13. [13]

    Liu, R., Zha, F., Ding, F., Yao, G., and Zhang, P. (2025). Skin Lesion Classification Based on ResNet-50 Enhanced With Adaptive Spatial Feature Fusion. arXiv preprint

    2025

  14. [14]

    R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., and Batra, D

    Selvaraju, R. R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., and Batra, D. (2017). Grad-CAM: Visual explanations from deep networks via gradient -based localization. In Proceedings of ICCV, pp. 618-626. 13

    2017

  15. [15]

    Cassidy, B., Kendrick, C., Brodzicki, A., Jaworek-Korjakowska, J., and Yap, M. H. (2022). Analysis of the ISIC image datasets: Usage, benchmarks and recommendations. Medical Image Analysis, 75, 102305

    2022